Nutraveris
Tuesday, January 31, 2017
Category : News, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The aim of this study was to compare the effect of two seeds (flax and Salba-chia) on postprandial glycemia and satiety scores.

Fifteen healthy participants (age: 23.9±3 years; BMI: 22.2±0.8 kg/m2) were randomized to receive a 50 g glucose challenge, alone or supplemented with either 25 g ground Salba-chia or 31.5 g flax, on three separate occasions.

Both Salba-chia and flax reduced blood glucose area under the curve over 120 min by 82.5 ±19.7 mmol/l (p<0.001) and 60.0 ±19.7 mmol/l (p=0.014), respectively, relative to a glucose control (Figure).

Salba-chia reduced peak glucose (-0.64 ±0.24 mmol/l; p=0.030) and increased time to peak (11.3 ±3.8 min; p=0.015) compared with flax.

Salba-chia significantly reduced the mean ratings of desire to eat (p=0.005), and overall appetite score (p=0.012), when compared with flax.

Salba-chia seed improve postprandial glycemia and satiety in a better way than flaxseed

Mean incremental blood glucose response in 15 healthy individuals after administration of Salba-chia, flax or control test beverages for: (a) 120 min postprandial and (b) incremental area under the curve after 120 min. Different letters are significantly different (p<0.05).

Salba-chia appears to have the ability to convert glucose into a slow-release carbohydrate and affect satiety to a greater extent than flax, possibly due to the higher fiber viscosity.

In conclusion, Salba-chia may confer additional benefit than flax.

Vuksan V, Choleva L, Jovanovski E, Jenkins AL, Au-Yeung F, Dias AG, Ho HV, Zurbau A, Duvnjak L. Comparison of flax (Linum usitatissimum) and Salba-chia (Salvia hispanica L.) seeds on postprandial glycemia and satiety in healthy individuals: a randomized, controlled, crossover study. Eur J Clin Nutr. 2016 Dec 21.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Leave a Reply